The stock of AngioDynamics Inc. (NASDAQ:ANGO) increased by $0.34 on Wednesday to $9.03, up 3.91 percent. The last five days have seen an average of 473,253 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$4.53. The average number of shares traded over the last 20 days was 441,658, while the average volume over the last 50 days totaled 417,251.
ANGO stock dropped -7.29% since last month. On 08/09/23, the company’s shares reached a one-month low of $8.06. The stock touched a high of $24.38 on 01/06/23, after rallying from a low of $8.06 in 52 weeks. The price of ANGO stock has declined by -34.42% or -$4.53 this year, reaching a new high 3 times. Still, the stock price is down -62.96% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
ANGO stock investors should be aware that AngioDynamics Inc. (ANGO) stock had its last reported insider trading activity 197 days ago on Jan 31. On Jan 31, SVP Global Operations and R&D Helsel Dave sold 4,633 shares at $12.95 each. This transaction resulted in the insider making $59,997. On Oct 12, Trowbridge Stephen A added 1,083 shares at a price of US$13.82. After the transaction, the insider now owns 89,581 shares. President and CEO Clemmer James C had earlier bought 10,000 shares on Oct 10 for $15.00 a share. The transaction was completed for $150,000.
Valuation Metrics
Beta for the stock is 0.59. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.03, the price-to-book (PB) ratio of 0.95.
Financial Health
For the three months ended May 30, AngioDynamics Inc.’s quick ratio was 1.30, while its current ratio was 2.00, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending May 30 is 0.13, and the total debt to equity ratio is 0.13. As far as profitability goes, gross margin for the trailing twelve months is 51.40% percent. AngioDynamics Inc.’s EBITDA margin for the year ended May 30 was 4.33%, whereas its operating margin stood at -15.10% for the same period. Based on annual data, it had gross profit of $174.25 million and revenue of $338.75 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. ANGO’s return on assets (ROA) during the last 12 months has been -9.60%. There was a -11.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -13.10%.
Earnings Surprise
According to AngioDynamics Inc.’s quarterly financial report for the quarter that ended May 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $90.57 million, while revenues rose by 3.94% to $80.71 million. It was predicted that AngioDynamics Inc.’s quarterly earnings would be $0.02, but it ended up being $0.02. EBITDA was $1.27 million for the quarter. At the end of AngioDynamics Inc.’s most recent quarter ended May 30, its liabilities totaled 154.34 million, while its total debt was $55.06 million. Equity owned by shareholders amounts to $39.67 million.
Technical Picture
Here’s a quick look at AngioDynamics Inc.’s (ANGO) price momentum from a technical perspective. As of 15 August, the RSI 9-day stood at 68.20%, suggesting the stock is Neutral, with a 37.77% historical volatility rate.
The stochastic %K and %D were 59.06% and 39.19% respectively, while the average true range (ATR) was 0.36. Based on the 14-day stochastic reading of 86.13%, the RSI (14) reading is 57.87%. On the 9-day MACD Oscillator, the stock is at 0.33, and the 14-day reading is at 0.30.
Analyst Ratings
AngioDynamics Inc. (NASDAQ: ANGO) was downgraded by Raymond James to a an Outperform rating in its latest research report. The stock was previously rated as a a Strong buy. Analysts have assigned AngioDynamics Inc. (ANGO) an Overweight rating. ANGO is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 1 other recommend it as a buy.
What is ANGO’s price target for the next 12 months?
The current consensus forecast for the stock is between $13.00 and $20.00, with a median target price of $16.50. In analyzing these forecasts, the average price target given by analysts for AngioDynamics Inc. (ANGO) is $16.50.
